Moderna has appointed Darius Hughes as UK General Manager in what the company considers an “important milestone” in its growth in the UK market.
Hughes joins Moderna following eight years as the head of Pfizer’s UK vaccines business unit where most recently he liaised with government, regulators and industry bodies to assist in the supply of Covid-19 vaccines in the UK.
Hughes was also Chair of the Association of the British Pharmaceutical Industry (ABPI) vaccines group. He previously held several roles within Pfizer across global, European and local teams. Prior to joining Pfizer, Hughes spent thirteen years at Boots the Chemist. Hughes is a registered pharmacist and holds a BSc in pharmacy from the University of Portsmouth, UK.
Dan Staner, Vice President and Head of Europe, Middle East & Africa for Moderna, said: “The UK is a key science and innovation hub in Europe and, as a leader in the mRNA space, we recognize the importance of growing our presence in the market. We see the appointment of Darius as an important milestone in this growth.”
Hughes said: “Recognition of Moderna has grown exponentially in the UK thanks to the important role it has played combating the Covid-19 pandemic. I look forward to leading Moderna’s continued support of the UK’s vaccination rollout and laying the foundations for the potentially groundbreaking mRNA programs pipeline.”